Authorizes artificial intelligence and machine learning technologies to prescribe pharmaceutical drugs if approved by the State involved and the Food and Drug Administration
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding federal statute (Act of Congress) that amends the Federal Food, Drug, and Cosmetic Act to create new legal definitions and requirements. It uses mandatory language and creates legally enforceable obligations through FDA regulatory pathways.
The document has minimal coverage of AI risk domains, with brief implicit mentions of approximately 3-4 subdomains. The primary focus is on authorizing AI to prescribe drugs, which touches on system safety (7.3 lack of robustness), governance (6.5), and potentially human-computer interaction (5.1 overreliance). Coverage is very limited as this is a short enabling statute rather than a comprehensive risk mitigation framework.
The document primarily governs the Health Care and Social Assistance sector by authorizing AI/ML technologies to prescribe pharmaceutical drugs. It also has implications for the Information sector (AI/ML technology developers) and Professional and Technical Services (companies developing healthcare AI solutions).
The document primarily covers the Deploy stage by establishing authorization requirements for AI/ML technologies to prescribe drugs. It implicitly touches on Verify and Validate through FDA approval requirements, and Operate and Monitor through ongoing state authorization requirements.
The document explicitly mentions both 'artificial intelligence' and 'machine learning technology' as the technologies authorized to prescribe drugs. It does not specify whether these are general purpose, task-specific, generative, or predictive AI, nor does it mention models, systems architecture, compute thresholds, or open-source considerations.
United States Congress
The document is titled as an Act and references Congressional authority to amend federal law. The authority is listed as 'United States Congress' in the document information.
Food and Drug Administration (FDA); State authorities
The FDA is responsible for approving, clearing, or authorizing AI/ML technologies under specified sections, while State authorities must authorize prescription capabilities pursuant to state statutes.
Food and Drug Administration (FDA); State regulatory authorities
The FDA monitors compliance through its existing medical device and drug regulatory framework (sections 510(k), 513, 515, 564), while state authorities monitor compliance with state prescription laws.
Developers and deployers of artificial intelligence and machine learning technologies for pharmaceutical prescription
The Act applies to entities developing and deploying AI and machine learning technologies that prescribe pharmaceutical drugs, requiring them to obtain FDA approval and state authorization.
3 subdomains (3 Minimal)